Loading...
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
The new oral anticoagulants (NOACs), which include dabigatran, rivaroxaban, apixaban, and edoxaban, are poised to replace warfarin for treatment of the majority of patients with venous thromboembolism (VTE). With a rapid onset of action and the capacity to be administered in fixed doses without rout...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4133479/ https://ncbi.nlm.nih.gov/pubmed/24923298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-03-563056 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|